Literature DB >> 18341667

Noninvasive biophysical assessments of the efficacy of a moisturizing cosmetic cream base for patients with atopic dermatitis during different seasons.

K Kikuchi1, H Tagami.   

Abstract

BACKGROUND: The use of emollients is recommended for patients with atopic dermatitis (AD) to maintain improved condition.
OBJECTIVES: To ascertain objectively the effectiveness of a moisturizing cream for patients with AD during different seasons.
METHODS: We conducted clinical evaluations, noninvasive biophysical measurements and biochemical analyses of the stratum corneum (SC) components of the volar forearm skin of 23 patients with AD after a moisturizer was applied twice daily for 4 weeks. The moisturizer was formulated according to the consensus of cosmetic scientists belonging to major Japanese cosmetic companies. The nontreated forearm served as a control.
RESULTS: After using the moisturizer treatment, the hydration of the SC significantly increased together with a decrease in the desquamation measurements and an improvement in the regularity of skin surface corneocytes. An improvement was observed in the SC barrier function in winter, but was achieved only after 4 weeks in late spring during which time there even occurred exacerbation of skin conditions in three patients. With use of the moisturizer treatment, we found no change in the SC content of free amino acids or ceramides, the ratio of interleukin (IL)-1 receptor antagonist to IL-1alpha, the ratio of immature to mature cornified envelopes, the size of the corneocytes or the emergence of parakeratotic cells in the skin surface corneocytes.
CONCLUSION: Treatment with an adequate moisturizer is beneficial for the dry skin of patients with AD during the dry, cold season but it does not influence the impaired SC barrier function as effectively in the less arid season.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18341667     DOI: 10.1111/j.1365-2133.2008.08478.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  6 in total

1.  Variation of skin surface pH, sebum content and stratum corneum hydration with age and gender in a large Chinese population.

Authors:  M Q Man; S J Xin; S P Song; S Y Cho; X J Zhang; C X Tu; K R Feingold; P M Elias
Journal:  Skin Pharmacol Physiol       Date:  2009-07-31       Impact factor: 3.479

2.  Treating atopic dermatitis: safety, efficacy, and patient acceptability of a ceramide hyaluronic acid emollient foam.

Authors:  Omar Pacha; Adelaide A Hebert
Journal:  Clin Cosmet Investig Dermatol       Date:  2012-05-07

3.  Efficacy of micronutrient supplementation on skin aging and seasonal variation: a randomized, placebo-controlled, double-blind study.

Authors:  Ferial Fanian; Sophie Mac-Mary; Adeline Jeudy; Thomas Lihoreau; Rafat Messikh; Jean-Paul Ortonne; Jean-Marie Sainthillier; Ahmed Elkhyat; Alexandre Guichard; Kamran Hejazi Kenari; Philippe Humbert
Journal:  Clin Interv Aging       Date:  2013-11-14       Impact factor: 4.458

4.  Changes in levels of omega-O-acylceramides and related processing enzymes of sun-exposed and sun-protected facial stratum corneum in differently pigmented ethnic groups.

Authors:  Anthony V Rawlings; Rotraut Schoop; Christian Klose; Jean-Marc Monneuse; Beverley Summers; Rainer Voegeli
Journal:  Int J Cosmet Sci       Date:  2022-03-13       Impact factor: 2.416

5.  Efficacy of Pseudo-Ceramide-Containing Steroid Lamellar Cream in Patients with Mild to Moderate Atopic Dermatitis: A Randomized, Double-Blind Study.

Authors:  Keita Okoshi; Yoshinori Kinugasa; Shotaro Ito; Takuji Kume; Tsuyoshi Seki; Takahiro Nishizaka; Joji Okada; Hiromitsu Kawada; Azumi Nagasawa; Makoto Iijima; Masatoshi Abe; Osamu Nemoto
Journal:  Dermatol Ther (Heidelb)       Date:  2022-07-19

6.  New Cosmetic Formulation for the Treatment of Mild to Moderate Infantile Atopic Dermatitis.

Authors:  Raúl de Lucas; Cristina García-Millán; Azahara Pérez-Davó; Esther Moreno; Pedro Redondo
Journal:  Children (Basel)       Date:  2019-01-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.